profit from every CHF 100 of sales.
CHF 0CHF 100
Tecan Group
CHF 260.40+0.77% today
+107.8% in 1 year
1-year low CHF 114.701-year high CHF 262.00
Trading close to its highest price of the past year.
The essentials
Four questions every investor asks, answered in one line each.
more sales each year, on average, 2022 to 2025.
0%20% a year
It has no yearly profit to compare the price with.
CheapExpensive
of earnings would pay off all its debt.
No debt5 years
Money in, money out
What Tecan Group sold, what it kept, and what it did with the cash.
Sales went from CHF 1.14 billion in 2022 to CHF 882 million in 2025, with -CHF 111 million of profit last year.
SalesProfit
Tecan Group handed back 70% of the cash it generated last year.
Buybacks CHF 33MCHF 38M
Free cash flow 2025CHF 103M
Bought back its own sharesCHF 33M
Paid as dividendsCHF 38M
Cash vs. debtCHF 176M vs. CHF 218M
Tecan Group vs. similar companies
How it compares with the largest companies in its industry.
| Company | Profit from CHF 100 of sales | Sales growth a year | Price per CHF 1 of profit |
|---|---|---|---|
| Tecan Group | No profit yet | ||
 Intuitive Surgical | 54.6× · Expensive | ||
 EssilorLuxottica Société anonyme | 36.1× · Expensive | ||
 Becton, Dickinson and | 34.8× · Expensive | ||
 Medline | 47.9× · Expensive |
AI analysis
An AI analyst reads Tecan Group's last five years, its segments, earnings, insiders and peers, and writes the bull case, the bear case and what the price expects.
Run the AI analysisFull statementsIncome, balance sheet and cash flow, year by year
Income statement
| In millions of CHF | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| 1,144 | 1,074 | 934 | 882 | |
| 438 | 390 | 321 | 311 | |
| 148 | 136 | 76 | 48 | |
| 211 | 206 | 148 | -37 | |
| 121 | 132 | 68 | -111 | |
| 9.47 | 10.30 | 5.29 | -8.74 | |
| 38.3% | 36.3% | 34.3% | 35.2% | |
| 12.9% | 12.7% | 8.1% | 5.4% | |
| 10.6% | 12.3% | 7.2% | -12.5% |
Balance sheet
| In millions of CHF | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| Total assets | 2,116 | 2,074 | 2,121 | 1,698 |
| Cash | 111 | 133 | 154 | 176 |
| Total debt | 308 | 316 | 321 | 218 |
| Total liabilities | 758 | 725 | 686 | 547 |
| 1,358 | 1,349 | 1,435 | 1,151 | |
| 13 | 13 | 13 | 13 | |
| – | – | – | – | |
| 8.9% | 9.8% | 4.7% | -9.6% |
Cash flow
| In millions of CHF | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| 128 | 161 | 149 | 138 | |
| 36 | 35 | 31 | 35 | |
| 92 | 126 | 118 | 103 | |
| Dividends paid | 36 | 37 | 38 | 38 |
| – | 0 | 29 | 33 | |
| 14 | 15 | 4 | 3 |
Valuation
- –
- –
- –
- 2.8×
- 3.6×
- 31.3×
- –
- 3.2%
- -3.4%
- 1.2%
Profitability
- 35.2%
- 5.4%
- -12.5%
- –
- -6.1%
- 3.0%
- –
- –
- –
- –
Growth
- −8.3%
- –
- –
- –
- −0.3%
Financial health
- –
- 0.19
- –
- -31.2×
- 2.46
- –
- –
How it ranks in Healthcare
Each dot is where the company stands among every company over $300M in the sector. Further right is better.
Bottom 27%of 958
Bottom 38%of 889
Bottom 9%of 890
Top 34%of 987
1.2%of the share price, paid each year
On $1,000 invested$12a year at today's yield, before tax
–per share
Raised–not every year
How safe it looks
: 37.0%
News
No recent news on file.
Insider trades
Our insider feed has not updated since May 26, 2026. Trades filed after that are not listed yet.
No insider trades on file.
The seven classic investing rulebooks
0/7Passes 0 of 7. Each bar is how well the company fits that investor's published rules, from 0 to 100; 60 or more counts as a pass.
Warren Buffett
20No pass
Benjamin Graham
38No pass
Philip Fisher
31No pass
Peter Lynch
27No pass
Joel Greenblatt
0No pass
Charlie Munger
29No pass
Terry Smith
21No pass
Questions about Tecan Group
Is Tecan Group a good stock to buy?
A business with weak numbers that is not profitable yet. 0 of the 7 famous investors' published rulebooks we apply pass it. Whether it suits you depends on your goals and the price you pay; invest-like never tells anyone to buy or sell. The AI analysis lays out the case for and against. Read the Tecan Group AI analysis
What does Tecan Group do?
Tecan Group AG provides laboratory instruments and solutions in biopharmaceuticals, forensics, and clinical diagnostics in Europe, North America, Asia, and internationally. It operates in two segments: Life Sciences Business and Partnering Business. It is in Medical Instruments & Supplies, based in Männedorf, Switzerland, with 3,026 employees.
Does Tecan Group pay a dividend?
Yes. At today's price the dividend is 1.2% a year. In 2025 it paid out CHF 38.0 million in dividends.
Is Tecan Group stock halal?
Yes. Tecan Group passes our halal screen: its business is permitted and its debt is 7% of its market value, under the 30% limit. How we check
How has Tecan Group stock done over the past year?
Up 107.8% over the past twelve months, to CHF 260.40. It traded between CHF 114.70 and CHF 262.00, close to its high.
Who are Tecan Group's competitors?
The largest listed companies in the same industry are Intuitive Surgical, EssilorLuxottica Société anonyme, Becton, Dickinson and and Medline. The peers table on this page compares their profit, growth and price with Tecan Group's.
Prices: daily closes to Nov 11, 2026. Fundamentals: company reports via invest-like data.